Viking Therapeutics Overview
Viking Therapeutics Target Price
Analysts' 12-month price predictions for VKTX.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.87
Average Target Price
$93.60
147.2% upside
147.2% upside5 analysts in the last 4 months
High: $101 | Low: $83
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-28 | Lake Street | $89 | 135% upside |  |
| 2026-05-27 | Truist FinancialGregory Renza | $83 | 119.2% upside | |
| 2026-04-30 | Morgan Stanley | $95 | 150.9% upside | |
| 2026-04-30 | Cantor FitzgeraldSteve Seedhouse | $100 | 164.1% upside | |
| 2026-03-12 | JefferiesRoger Song | $101 | 166.7% upside | |
| 2026-02-12 | Morgan StanleyMichael Ulz | $99 | 161.4% upside | |
| 2025-11-12 | Canaccord GenuityEdward Nash | $107 | 182.5% upside | |
| 2025-10-29 | Canaccord GenuityEdward Nash | $106 | 179.9% upside | |
| 2025-10-23 | Morgan Stanley | $102 | 169.3% upside | |
| 2025-10-23 | Cantor Fitzgerald | $105 | 177.3% upside | |
| 2025-04-28 | Truist FinancialJoon Lee | $75 | 98% upside | |
| 2024-12-02 | Piper SandlerBiren Amin | $74 | 95.4% upside | |
| 2024-11-04 | LaidlawYale Jen | $110 | 190.5% upside | |
| 2024-11-04 | JefferiesRoger Song | $110 | 190.5% upside | |
| 2024-06-27 | Morgan StanleyMichael Ulz | $105 | 177.3% upside | |
| 2024-06-25 | H.C. WainwrightJoseph Pantginis | $90 | 137.7% upside | |
| 2024-05-16 | Raymond JamesSteve Seedhouse | $116 | 206.3% upside | |
| 2024-05-16 | Truist FinancialJoon Lee | $120 | 216.9% upside | |
| 2024-03-26 | Stifel NicolausSamimy Annabel | $95 | 150.9% upside | |
| 2024-03-26 | OppenheimerJay Olson | $138 | 264.4% upside | |
| 2024-03-26 | BTIGJustin Zelin | $125 | 230.1% upside | |
| 2024-03-15 | BTIGJustin Zelin | $100 | 164.1% upside | |
| 2022-12-24 | Maxim GroupMaxim Maxim | $15 |  60.4% downside | |
| 2022-12-19 | BTIGJustin Zelin | $20 | 47.2% downside | |
| 2022-12-19 | H.C. WainwrightJoseph Pantginis | $21 | 44.5% downside | |